Instem plc No Exposure to Silicon Valley Bank (7227S)

TIDMINS

RNS Number : 7227S

Instem plc

13 March 2023

Instem plc

("Instem", the "Group" or the "Company")

No Exposure to Silicon Valley Bank

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, notes media reports indicating the closure of Silicon Valley Bank ("SVB"). The Company does not hold any cash at SVB and it does not have a banking relationship with or any exposure to SVB.

For further information, please contact:

 
 Instem plc                              Via Walbrook 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 Singer Capital Markets (Nominated 
  Adviser & Broker)                      +44 (0) 20 7496 3000 
 Peter Steel 
  Alex Bond 
  Oliver Platts 
 
 Stifel Nicolaus Europe Limited (Joint 
  Broker)                                +44 (0) 20 7710 7600 
 Ben Maddison 
 Alex Price 
  Richard Short 
 
 Walbrook Financial PR                   +44 (0) 20 7933 8780 
 Tom Cooper                              instem@walbrookpr.com 
 Nick Rome 
  Joe Walker

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management, Regulatory Submissions, Clinical Trial Acceleration, and Informatics-based Insight Generation.

Instem solutions are in use by over 700 customers worldwide, including all of the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform during their development.

   To learn more about Instem solutions and its mission, please visit   www.instem.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFIFFDVRIVLIV

(END) Dow Jones Newswires

March 13, 2023 03:30 ET (07:30 GMT)

Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024